Atika Capital Management LLC - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
Atika Capital Management LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$3,120,000
-3.0%
98,000
+15.3%
1.07%
-14.0%
Q4 2017$3,215,000–85,000–1.24%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders